Immunofocus™
Predict the response to anti PD1/PDL1 directed therapies.
The Immunofocus™ assay assesses PD-L1 expression in tumors based on the immuno-histochemical staining of routine diagnostic histological material with an anti-PD-L1 antibody, clone E1L3N, Cell Signaling Technology. Source
Get started
To start making requests, simply fill out the registration form below.
Have an account? Sign in.